Human evidence first
Randomised human trials carry more weight than mechanisms or laboratory findings alone.
Built on studies.
Not hype.
Every active is disclosed with its exact dose. Explore the human evidence behind the ingredients, how closely each study matches Ava, and where the science is still developing.
Evidence, read in context.
16Disclosed active nutrients
3Functional systems
0Proprietary blends
3rdParty tested
Context changes
the conclusion.
“Science-backed” means little without the study design, population, ingredient form and dose. We show the match as well as the limitations.
Dose and form matter
We compare the researched amount and extract specification with the amount and form in Ava.
Limitations stay visible
Mixed findings, small samples and different populations are shown—not edited out.
Sustained support,
without the spike.
Ava designTypical stimulant profile
Illustrative model only. This graph explains the formulation strategy; it is not measured clinical outcome data for the finished Ava product and does not predict an individual response.
Find the
evidence.
Search selected human trials and evidence reviews relevant to Ava’s ingredients. Filter by ingredient or by the role it plays in the formula.
CiticolineRCT · 2021
Citicoline and memory in healthy older adults
100 participants · 500 mg/day · 12 weeks
Relevant dose; population had age-associated memory impairment.Read study ↗Nicotinamide ribosideRCT · 2019
Safety and NAD+ metabolism
140 participants · 100–1,000 mg/day · 8 weeks
Shows a biomarker effect; does not establish a subjective energy benefit.Read study ↗Lion’s maneRCT · 2009
Lion’s mane in mild cognitive impairment
30 participants · 3 g/day powder · 16 weeks
Promising outcome; form, dose and population differ from Ava.Read study ↗Coenzyme Q10Crossover RCT · 2008
CoQ10 during a fatigue-inducing physical task
17 participants · 100 or 300 mg/day · 8 days
Small sample; strongest signal appeared at the higher dose.Read study ↗Acetyl-L-carnitineEvidence review · 2017
ALCAR for cognitive enhancement
Cochrane evidence review
Too little reliable evidence for conclusions in healthy adults.Read review ↗N-Acetyl-L-CysteineSystematic review · 2017
NAC and human cognition
Review of clinical evidence
The literature was heterogeneous and underpowered for firm conclusions.Read review ↗AstaxanthinRCT · 2010
Astaxanthin and oxidative biomarkers
0, 2 or 8 mg/day · 8 weeks
Dose-aligned biomarker research; not a direct performance outcome.Read study ↗AstaxanthinMeta-analysis · 2024
Fatigue, motor function and cognition
11 RCTs · 346 healthy participants
Cognitive accuracy was marginal; reaction time was not significant.Read analysis ↗Rhodiola roseaRCT · 2014
Rhodiola for shift-work fatigue
48 nursing students · 364–728 mg/day · 42 days
The primary result favoured placebo—an important contradictory finding.Read study ↗Panax ginsengCrossover trial · 2020
Ginseng, attention and perceived stress
Pilot human crossover research
Results are extract-specific and cannot be transferred automatically.Read study ↗No matching studies.
Try a broader search or reset the filters.
Transparency before certainty.
The research above evaluates individual ingredients, often in different populations, forms, doses and durations. It does not prove that the finished Ava formula will produce identical outcomes.
Ava is a food supplement, not a medicine, and is not intended to diagnose, treat, cure or prevent disease.
Explore Focused Energy →